HemoShear Therapeutics Appoints Patrick Horn, MD, PhD, Chief Medical Officer

Industry Veteran Will Lead HST5040 and Future Rare Disease Clinical Programs CHARLOTTESVILLE, Va., Dec. 14, 2021 -- (Healthcare Sales & Marketing Network) -- HemoShear Therapeutics, Inc., a privately held biotechnology company developing drugs for rare... Biopharmaceuticals, Personnel HemoShear Therapeutics, REVEAL-Tx
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news